id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-4615-0009,FDA,FDA-2015-E-4615,Letter from the U.S. Patent and Trademark Office to Morrison & Foerster  LLP,Other,Letter(s),2018-05-10T04:00:00Z,2018,5,2018-05-10T04:00:00Z,,2018-05-10T17:19:31Z,,0,0,0900006483255e79
FDA-2015-E-4615-0008,FDA,FDA-2015-E-4615,Letter from the U.S. Patent and Trademark Office to Morrison & Foerster  LLP,Other,Letter(s),2018-05-10T04:00:00Z,2018,5,2018-05-10T04:00:00Z,,2018-05-10T17:14:58Z,,0,0,0900006483255e76
FDA-2015-E-4615-0007,FDA,FDA-2015-E-4615,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2018-01-29T05:00:00Z,2018,1,2018-01-29T05:00:00Z,,2018-01-29T20:35:07Z,,0,0,0900006482e79dda
FDA-2015-E-4615-0006,FDA,FDA-2015-E-4615,"Determination of Regulatory Review Period for Purposes of Patent
Extension; Intercept Blood System for Plasma",Notice,Determinations,2017-07-11T04:00:00Z,2017,7,2017-07-11T04:00:00Z,2017-09-12T03:59:59Z,2017-07-11T14:05:32Z,2017-14454,0,0,090000648290a592
FDA-2015-E-4615-0005,FDA,FDA-2015-E-4615,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2017-06-07T04:00:00Z,2017,6,2017-06-07T04:00:00Z,,2017-06-07T16:23:37Z,,0,0,09000064826a207f
FDA-2015-E-4615-0004,FDA,FDA-2015-E-4615,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T18:45:29Z,,0,0,0900006482438638
FDA-2015-E-4615-0003,FDA,FDA-2015-E-4615,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-05-02T04:00:00Z,2016,5,2016-05-02T04:00:00Z,,2016-05-02T23:30:11Z,,0,0,0900006481fa1d4c
FDA-2015-E-4615-0001,FDA,FDA-2015-E-4615,Patent Extension Application from Morrison & Foerster LLP (on behalf of Cerus Corporation),Other,Application,2015-12-04T05:00:00Z,2015,12,2015-12-04T05:00:00Z,,2015-12-04T17:31:46Z,,0,0,0900006481d866e5
FDA-2015-E-4615-0002,FDA,FDA-2015-E-4615,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2015-12-04T05:00:00Z,2015,12,2015-12-04T05:00:00Z,,2015-12-04T17:32:20Z,,0,0,0900006481d866e6